These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26469187)

  • 1. Common Immunosuppressive Monotherapy for Graves' Ophthalmopathy: A Meta-Analysis.
    Mou P; Jiang LH; Zhang Y; Li YZ; Lou H; Zeng CC; Wang QH; Cheng JW; Wei RL
    PLoS One; 2015; 10(10):e0139544. PubMed ID: 26469187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of methylprednisolone pulse therapy for Graves' ophthalmopathy.
    Gao G; Dai J; Qian Y; Ma F
    Clin Exp Ophthalmol; 2014 Nov; 42(8):769-77. PubMed ID: 24617953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous glucocorticoids therapy in the treatment of Graves' ophthalmopathy: a systematic review and Meta-analysis.
    Zhao LQ; Yu DY; Cheng JW
    Int J Ophthalmol; 2019; 12(7):1177-1186. PubMed ID: 31341811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment strategies for Graves' ophthalmopathy: a network meta-analysis.
    Zhou X; Zhou D; Wang J; Chen G
    Br J Ophthalmol; 2020 Apr; 104(4):551-556. PubMed ID: 31272958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves' ophthalmopathy.
    Aktaran S; Akarsu E; Erbağci I; Araz M; Okumuş S; Kartal M
    Int J Clin Pract; 2007 Jan; 61(1):45-51. PubMed ID: 16889639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graves' orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis.
    Vannucchi G; Campi I; Covelli D; Dazzi D; Currò N; Simonetta S; Ratiglia R; Beck-Peccoz P; Salvi M
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3381-6. PubMed ID: 19567525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Efficacy of Medical Treatments for Thyroid Eye Disease: A Network Meta-Analysis.
    Xu N; Cui Y; Xie T; Zheng M
    J Ophthalmol; 2018; 2018():7184163. PubMed ID: 30647961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Rituximab for the Treatment of Graves' Orbitopathy: A Meta-analysis of Randomized Controlled Trials.
    Shen WC; Lee CH; Loh EW; Hsieh AT; Chen L; Tam KW
    Pharmacotherapy; 2018 May; 38(5):503-510. PubMed ID: 29601105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence That Baseline Levels of Low-Density Lipoproteins Cholesterol Affect the Clinical Response of Graves' Ophthalmopathy to Parenteral Corticosteroids.
    Naselli A; Moretti D; Regalbuto C; Arpi ML; Lo Giudice F; Frasca F; Belfiore A; Le Moli R
    Front Endocrinol (Lausanne); 2020; 11():609895. PubMed ID: 33414766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of tripterygium glycosides for Graves ophthalmopathy: A systematic review and meta-analysis.
    Liu X; Gao C; Liu X; Gao T
    Medicine (Baltimore); 2019 Dec; 98(50):e18242. PubMed ID: 31852090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves' Orbitopathy.
    Campi I; Vannucchi G; Muller I; Lazzaroni E; Currò N; Dainese M; Montacchini B; Covelli D; Guastella C; Pignataro L; Fugazzola L; Arosio M; Salvi M
    Front Endocrinol (Lausanne); 2021; 12():790246. PubMed ID: 35145479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of different treatment modalities for active, moderate-to-severe Graves' orbitopathy: a systematic review and network meta-analysis.
    Li H; Yang L; Song Y; Zhao X; Sun C; Zhang L; Zhao H; Pan Y
    Acta Ophthalmol; 2022 Sep; 100(6):e1189-e1198. PubMed ID: 34918472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves' ophthalmopathy.
    Tachibana S; Murakami T; Noguchi H; Noguchi Y; Nakashima A; Ohyabu Y; Noguchi S
    Endocr J; 2010; 57(10):853-61. PubMed ID: 20733265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic outcome to intravenous steroid therapy for active Graves' orbitopathy is influenced by the time of response but not polymorphisms of the glucocorticoid receptor.
    Vannucchi G; Covelli D; Campi I; Origo D; Currò N; Cirello V; Dazzi D; Beck-Peccoz P; Salvi M
    Eur J Endocrinol; 2014 Jan; 170(1):55-61. PubMed ID: 24128430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VARIABLES AFFECTING THE LONG-TERM OUTCOME OF GRAVES ORBITOPATHY FOLLOWING HIGH-DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY.
    Leo M; Mautone T; Ionni I; Profilo MA; Sabini E; Menconi F; Mazzi B; Rocchi R; Latrofa F; Nardi M; Vitti P; Marcocci C; Marinò M
    Endocr Pract; 2016 Oct; 22(10):1177-1186. PubMed ID: 27732097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New immunomodulators in the treatment of Graves' ophthalmopathy.
    Salvi M; Vannucchi G; Campi I; Currò N; Beck-Peccoz P
    Ann Endocrinol (Paris); 2008 Apr; 69(2):153-6. PubMed ID: 18417090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis.
    Stiebel-Kalish H; Robenshtok E; Hasanreisoglu M; Ezrachi D; Shimon I; Leibovici L
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2708-16. PubMed ID: 19491222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy for Graves' ophthalmopathy: a systematic review and meta-analysis of randomized controlled trials.
    Viani GA; Boin AC; De Fendi LI; Fonseca EC; Stefano EJ; Paula JS
    Arq Bras Oftalmol; 2012 Oct; 75(5):324-32. PubMed ID: 23471326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical review: Intravenous glucocorticoids for Graves' orbitopathy: efficacy and morbidity.
    Zang S; Ponto KA; Kahaly GJ
    J Clin Endocrinol Metab; 2011 Feb; 96(2):320-32. PubMed ID: 21239515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Patients With Dysthyroid Optic Neuropathy Treated With Intravenous Corticosteroids and/or Orbital Decompression Surgery: A Systematic Review and Meta-analysis.
    Wang M; Jiang X; Geng J; Hui S; Li D
    J Clin Endocrinol Metab; 2023 Sep; 108(10):2717-2727. PubMed ID: 37066814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.